Page last updated: 2024-09-04

carbapenems and acetylglucosamine

carbapenems has been researched along with acetylglucosamine in 2 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(acetylglucosamine)
Trials
(acetylglucosamine)
Recent Studies (post-2010) (acetylglucosamine)
7,3551475,2775,674312,001

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)acetylglucosamine (IC50)
Cytochrome P450 3A4Homo sapiens (human)1.9953
Cannabinoid receptor 1Rattus norvegicus (Norway rat)2.5119
Killer cell lectin-like receptor subfamily B member 1ARattus norvegicus (Norway rat)2.2536

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hesek, D; Lee, M; Mobashery, S; Vakulenko, SB; Villegas-Estrada, A1
Li, M; Skalweit, MJ1

Other Studies

2 other study(ies) available for carbapenems and acetylglucosamine

ArticleYear
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.
    Journal of the American Chemical Society, 2008, Jul-23, Volume: 130, Issue:29

    Topics: Acetylglucosamine; Anti-Bacterial Agents; Binding Sites; Biomimetic Materials; Carbapenems; Ceftaroline; Cell Wall; Cephalosporins; Circular Dichroism; Kinetics; Methicillin Resistance; Muramic Acids; Penicillin-Binding Proteins; Peptide Synthases; Peptidoglycan; Protein Conformation; Staphylococcus aureus

2008
Bulgecin A as a β-lactam enhancer for carbapenem-resistant
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Acetylglucosamine; Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Enzyme Inhibitors; Proline; Pseudomonas aeruginosa

2016